Skip to main content
Schouw & Co. logo

Schouw & Co. — Investor Relations & Filings

Ticker · SCHO ISIN · DK0010253921 LEI · 213800V2R9WMMZASKK57 CO Financial and insurance activities
Open in API
Filings indexed 1,456 across all filing types
Latest filing 2024-11-12 Delisting Announcement
Country DK Denmark
Listing CO SCHO

About Schouw & Co.

https://www.schouw.com

Schouw & Co. is an industrial conglomerate that makes long-term investments in a diversified portfolio of leading businesses. The company practices active and developing ownership to create sustainable, long-term value. Its portfolio consists of several independent businesses that operate as focused sub-groups within their own segments, primarily engaging in business-to-business production and commerce. Key sectors include feed for industrial fish farming and non-woven textiles for personal care applications. The business model emphasizes a resilient and decentralized operational structure, allowing each entity to develop its market position while benefiting from the conglomerate's strategic oversight and financial strength.

Recent filings

Filing Released Lang Actions
Delisting Announcement 2024
Delisting Announcement Classification · 99% confidence The document is a formal announcement titled "Schouw & Co. initiates evaluation of a possible separate listing of BioMar." It is addressed to the Danish Financial Supervisory Authority and Nasdaq Copenhagen, indicating it is a regulatory disclosure. The content discusses a potential corporate action (a spin-off/IPO) concerning a subsidiary, which relates to capital structure and financing activities. Since it is an announcement about a potential future capital event rather than the final execution of a financing round (CAP) or a general regulatory filing (RNS), and it deals specifically with corporate structure changes, it fits best under Capital/Financing Update (CAP) or potentially a general Regulatory Filing (RNS). Given the specific nature of evaluating a separate listing, which is a major capital structure event, CAP is a strong candidate. However, because this is an initial announcement of an *evaluation* of a potential IPO/listing, and not the final financing document itself, and it is a general corporate announcement, RNS (Regulatory Filings - the fallback for miscellaneous regulatory announcements) is often used for these initial strategic disclosures in European markets when a more specific code like 'CAP' is reserved for the actual issuance/offering documents. Given the options, and that it is a formal company announcement regarding a strategic corporate action that impacts capital structure, I will classify it as a general Regulatory Filing (RNS) as it is a broad disclosure to the market, although CAP is closely related. Since it is a formal, non-standard announcement, RNS is the safest general regulatory classification.
2024-11-12 English
Regulatory Filings 2024
Regulatory Filings Classification · 100% confidence The document is a formal announcement titled 'SELSKABSMEDDELELSE' (Company Announcement) from Schouw & Co. to FINANSTILSYNET (Danish FSA) and NASDAQ COPENHAGEN. The core subject is the initiation of an evaluation for a potential separate stock market listing (børsnotering) of its subsidiary, BioMar. This action directly relates to changes in the company's capital structure, financing strategy, and potential future share offerings. This fits best under 'Capital/Financing Update' (CAP), as it announces the exploration of a major financing/structural event. It is not a full financial report (10-K or IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI). Since it is an announcement about a potential capital event, CAP is the most precise fit over the general 'RNS'. The document length (4136 chars) is short enough that if it were just announcing the publication of a larger document, RPA/RNS might apply, but here the announcement *is* the material event itself (the evaluation decision).
2024-11-12 Danish
Report Publication Announcement 2024
Report Publication Announcement Classification · 99% confidence The document is a press release announcing that Schouw & Co. has initiated an evaluation for a possible separate listing (IPO) of its subsidiary, BioMar. This action relates to corporate structure, financing strategy, and potential capital market activities. It is not a full annual report (10-K), an earnings release (ER), or a standard quarterly report (IR). It specifically discusses a potential capital market event (IPO/listing) and its implications for the parent company's capital structure and portfolio management. This aligns best with the 'Capital/Financing Update' category (CAP), as it details a major potential change in capital structure and fundraising strategy, even though it is an evaluation phase. It is not a formal M&A announcement (TAR) as it is an internal spin-off/listing plan, nor is it a general regulatory filing (RNS) given the specific nature of the announcement.
2024-11-12 English
M&A Activity 2024
M&A Activity Classification · 99% confidence The document is a press release from Schouw & Co. announcing that the Board of Directors has decided to evaluate the possibilities of a separate stock exchange listing (IPO) for its subsidiary, BioMar. This announcement concerns a potential future capital structure change or financing activity related to a major subsidiary. Since it is an announcement about a potential future corporate action (spin-off/IPO) and not the final filing for the action itself, it fits best under Capital/Financing Update (CAP) or potentially a general Regulatory Filing (RNS) if CAP is too specific for an *evaluation*. Given the core subject is a potential spin-off/listing, CAP is the most appropriate category for major financing/capital structure decisions. The document is short and is announcing an event, not providing the full details of a financial report.
2024-11-12 Danish
Report Publication Announcement 2024
Report Publication Announcement Classification · 99% confidence The document is a formal announcement titled "Schouw & Co. initiates evaluation of a possible separate listing of BioMar." It is addressed to the Danish Financial Supervisory Authority and Nasdaq Copenhagen, indicating it is a regulatory disclosure. The content discusses a potential corporate action (a spin-off/IPO) concerning a subsidiary, which relates to capital structure and financing activities. Since it is an announcement about a potential future capital event rather than the final execution of a financing round (CAP) or a general regulatory filing (RNS), and it deals specifically with corporate structure changes, it fits best under Capital/Financing Update (CAP) or potentially a general Regulatory Filing (RNS). Given the specific nature of evaluating a separate listing, which is a major capital structure event, CAP is a strong candidate. However, because this is an initial announcement of an *evaluation* of a potential IPO/listing, and not the final financing document itself, and it is a general corporate announcement, RNS (Regulatory Filings - the fallback for miscellaneous regulatory announcements) is often used for these initial strategic disclosures in European markets when a more specific code like 'CAP' is reserved for the actual issuance/offering documents. Given the options, and that it is a formal company announcement regarding a strategic corporate action that impacts capital structure, I will classify it as a general Regulatory Filing (RNS) as it is a broad disclosure to the market, although CAP is closely related. Since it is a formal, non-standard announcement, RNS is the safest general regulatory classification.
2024-11-12 English
Regulatory Filings 2024
Regulatory Filings Classification · 95% confidence The provided document text consists almost entirely of tables showing 'Volume', 'Price/Venue' (XCSE, indicating a Swedish exchange), and 'Time CET'. This structure is characteristic of real-time or delayed trade reporting data, often disseminated via regulatory feeds or market data services. None of the provided definitions (AGM-R, 10-K, ER, CT, etc.) match raw trade data. Since this is raw market activity data and does not fit any specific corporate disclosure category like financial reports, management changes, or shareholder actions, the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as a general category for miscellaneous regulatory announcements or data feeds that don't fit elsewhere. The document length is substantial (26,407 chars), but the content type is purely transactional data, not a narrative report.
2024-11-11 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.